Evaluating the Use of Thromboelastography to Diagnose Coagulopathy After Traumatic Brain Injury

Traumatic Brain Injury Clinical Trial

Official title:

Evaluating the Use of Thromboelastography to Diagnose and Monitor Coagulopathy Associated With Pediatric Traumatic Brain Injury

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01589172
• Other study ID #: 120296
• Status: Completed
• Start date: May 1, 2012
• Est. completion date: November 30, 2012

Study information

• Verified date: February 2020
• Source: University of California, San Diego
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The investigators will obtain thromboelastography (TEG) on pediatric patients admitted to the Rady Children's Hospital ICU after traumatic brain injury on admission to our ICU and after 24 hours of care. The investigators hypothesize that TEG will identify abnormalities of coagulation that are not identified by traditional coagulation studies, i.e. prothrombin time (PT), activated partial thromboplastin time (aPTT), and international normalized ratio (INR).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: November 30, 2012
• Est. primary completion date: November 30, 2012
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A to 15 Years

Eligibility

Inclusion Criteria:

• less than 15 years of age

• evidence of intracranial bleed on CT scan or GCS <12

Exclusion Criteria:

• No intracranial hemorrhage or

• GCS 13 - 15

Related Conditions & MeSH terms

• Blood Coagulation Disorders
• Brain Injuries
• Brain Injuries, Traumatic
• Coagulation Disorder
• Hemostatic Disorders
• Traumatic Brain Injury
• Wounds and Injuries

Locations

Country	Name	City	State
United States	Rady Children's Hospital	San Diego	California

Sponsors (1)

Lead Sponsor	Collaborator
University of California, San Diego

Country where clinical trial is conducted

United States,